Current research in the lab focuses upon the differentiation of iPS cells into retinal neurons, with important implications for the study of blinding neurodegenerative diseases.
His research focuses upon the differentiation of retinal ganglion cells from human pluripotent stem cells, including the derivation of glaucoma models through iPS cell reprogramming as well as Crispr/Cas9 gene editing. Ongoing projects in his lab explore the use of these cells for studies of RGC development as well as mechanisms underlying glaucomatous neurodegeneration.
Expertise:
- Neurodegenerative Disorders Research
- Neurodevelopment Research
- Ocular Neurobiology Research
- Spinal Cord and Brain Injury Research
